H.U. Group Holdings Inc. (4544) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for H.U. Group Holdings Inc. (4544:JPX), powered by AI.

Current Price
¥3,190
P/E Ratio
65.7
Market Cap
181.2B
Sector
Healthcare
What is the H.U. Group Holdings Inc. stock price forecast?

H.U. Group Holdings Inc. is currently trading at ¥3,190. View real-time AI analysis on Alpha Lenz.

What is H.U. Group Holdings Inc. insider trading activity?

View the latest insider trading data for H.U. Group Holdings Inc. on Alpha Lenz.

What is H.U. Group Holdings Inc.'s P/E ratio?

H.U. Group Holdings Inc.'s P/E ratio is 65.7.

H.U. Group Holdings Inc.

JPX · 4544
¥3,190-61(-1.88%)Market closedJPX regular session 09:00–15:00 JST
Ask about H.U. Group Holdings Inc.'s future dividend policy...
Alpha Chat Insight

H.U. Group Holdings Inc. trades at a P/E of 65.7 (premium valuation) with modest ROE of 2.0%.

Ask for details

Company Overview

H.U. Group Holdings Inc. is a leading company in the healthcare and diagnostics sector, primarily focused on clinical testing, diagnostics, and related services. The company provides comprehensive laboratory services, including testing for a wide array of medical conditions, ranging from routine blood tests to sophisticated genetic analyses. H.U. Group Holdings also supplies diagnostic products and develops innovative testing solutions, contributing significantly to the healthcare industry's capacity to deliver precise and timely diagnosis. The firm plays a crucial role in advancing medical research and public health through its services, impacting both healthcare providers and patients alike. By maintaining robust testing capabilities and fostering technological advancements, H.U. Group Holdings supports healthcare systems in managing and combating diseases more effectively. As a key player in the healthcare market, it serves hospitals, clinics, and various other healthcare institutions, ensuring they have access to essential diagnostic tools and information. Founded in Japan, H.U. Group Holdings continues to expand its influence, underpinning its essential role in global healthcare infrastructure with a commitment to quality and innovation.

CEOMr. Shigekazu Takeuchi
SectorHealthcare
IndustryDiagnostics & Research
Employees5,444

Company Statistics

FY 2025

Profile

¥181,226,133,000Market Cap
¥243,025,000,000Revenue
0.00Shares Out
5,444Employees

Margins

27.65%Gross
9.47%EBITDA
1.09%Operating
1.32%Pre-Tax
1.12%Net

Valuation

65.66P/E
1.32P/B
0.75EV/Sales
9.87EV/EBITDA
15.56P/FCF

Growth (CAGR)

-3.80%Rev 3Yr
5.19%Rev 5Yr
-62.60%Op Inc 3Yr
-23.29%Op Inc 5Yr
-54.82%Net Inc 3Yr
N/ANet Inc 5Yr

Returns

0.96%ROA
1.97%ROE
1.33%ROIC

Financial Health

¥40,885,000,000Cash & Cash Equivalents
¥101,405,000,000Net Debt
103.64%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

H.U. Group Holdings Inc. (ticker: 4544) is a company listed on JPX in the Healthcare sector (Diagnostics & Research). It has approximately 5,444 employees. Market cap is $181.2B.

The current price is 3,190 with a P/E ratio of 65.66x and P/B of 1.32x.

ROE is 1.97% and operating margin is 1.09%. Annual revenue is $243.0B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
H.U. Group Holdings Inc. (4544) Stock Forecast 2026 ¥3,190 — Price, Financials & Analyst Targets | Alpha Lenz